| Patents for A61K 38 - Medicinal preparations containing peptides (316,240) |
|---|
| 05/04/2011 | EP2316968A1 Antisense modulation of apolipoprotein (A) expression |
| 05/04/2011 | EP2316953A2 Identification of novel E2F target genes and use thereof |
| 05/04/2011 | EP2316951A1 Binding domain-immunoglobulin fusion proteins |
| 05/04/2011 | EP2316944A2 Binding agents: chimeric ligand/receptor proteins |
| 05/04/2011 | EP2316939A2 Novel peptide |
| 05/04/2011 | EP2316930A1 Human coagulation factor VII polypeptides |
| 05/04/2011 | EP2316850A2 HASylated polypeptides, especially HASylated erythropoietin |
| 05/04/2011 | EP2316849A2 Polypeptides comprising RER, derivatives and uses thereof |
| 05/04/2011 | EP2316846A2 Spatially-defined macrocyclic compounds useful for drug discovery |
| 05/04/2011 | EP2316845A1 Specific binding agents of human angiopoietin-2 |
| 05/04/2011 | EP2316531A1 Augmented cognitive training |
| 05/04/2011 | EP2316529A1 Compositions and methods for treatment of body weight conditions with enzyme inhibiting peptides |
| 05/04/2011 | EP2316497A2 Supplemented matrices for the repair of bone fractures |
| 05/04/2011 | EP2316490A2 Methods and compositions for enhanced delivery of bioactive molecules |
| 05/04/2011 | EP2316479A2 Pharmaceutical compositions comprising immunologically active herpes simplex virus (HSV) protein fragments |
| 05/04/2011 | EP2316477A1 Immunogenic LHRH compositions and methods relating thereto |
| 05/04/2011 | EP2316476A2 Antigenic peptides derived from telomerase |
| 05/04/2011 | EP2316475A1 Isolated tetrameric uricase |
| 05/04/2011 | EP2316474A1 Pregnancy-related enzyme PC 5/6 antagonists |
| 05/04/2011 | EP2316473A1 Use of calcitonin in osteoarthritis |
| 05/04/2011 | EP2316472A1 Composition for transmucosal delivery of polypeptides |
| 05/04/2011 | EP2316471A1 Pharmaceutical formulations for sustained drug delivery |
| 05/04/2011 | EP2316470A2 Peptidomimetic inhibitors of post-proline cleaving enzymes |
| 05/04/2011 | EP2316469A1 Delivery system and methods for protecting and administering dextroamphetamine |
| 05/04/2011 | EP2316468A1 Delivery system and methods for protecting and administering dextroamphetamine |
| 05/04/2011 | EP2316467A1 Use of a prolactin variant for treating cancer |
| 05/04/2011 | EP2316436A1 Tape, in particular adhesive tape, for the treatment of skin disorders comprising a film , in particular dissolvable film, containing at least one enzyme |
| 05/04/2011 | EP2316427A1 Compositions and methods for improved delivery of hydrophobic therapeutic agents |
| 05/04/2011 | EP2316419A1 Aerosolized fosfomycin/aminoglycoside combination for the treatment of bacterial respiratory infections |
| 05/04/2011 | EP2315834A1 The tuberculosis rv2386c protein, compositions and uses thereof |
| 05/04/2011 | EP2315776A2 T cell receptors and related materials and methods of use |
| 05/04/2011 | EP2315771A2 Glycopeptide constructs and uses thereof |
| 05/04/2011 | EP2315603A1 Polysaccharide-protein conjugates reversibly coupled via imine bonds |
| 05/04/2011 | EP2315602A2 Methods for dosing an actriib antagonist and monitoring of treated patients |
| 05/04/2011 | EP2315577A2 Dermocosmetic composition, aesthetic treatment method using the composition, and use of the composition for lightening the pigmentation of the skin |
| 05/04/2011 | EP1879572B1 Use of antagonists of oxytocin and/or vasopressin in assisted reproduction |
| 05/04/2011 | EP1855661B1 Formulation for aviptadil |
| 05/04/2011 | EP1771199B9 Long-acting colloidal insulin formulation and preparation thereof |
| 05/04/2011 | EP1733231B1 Peptides and peptidomimetics binding to cd23 |
| 05/04/2011 | EP1725660B1 Multiple promoter expression cassettes for simultaneous delivery of rnai agents |
| 05/04/2011 | EP1703899B1 Stabilised compositions of factor vii polypeptides |
| 05/04/2011 | EP1613397B1 Use of bacteriocin for the amelioration of digestive functionality |
| 05/04/2011 | EP1581560B1 Anti-idiotypic antibodies against factor viii inhibitor and uses thereof |
| 05/04/2011 | EP1530643B1 Chimeric protein |
| 05/04/2011 | EP1446100B1 Injectable depot compositions and uses thereof |
| 05/04/2011 | EP1414439B1 Novel pyrroles having hypolipidemic hypocholesteremic activities, process for their preparation and pharmaceutical compositions containing them and their use in medicine |
| 05/04/2011 | EP1353684B1 Use of inhibitors of dipeptidypeptidase iv (ec 3.3.14.5) and aminopeptidase n (ec 3.4.11.2) for the treatment of neurodegeneration induced by ischaemia |
| 05/04/2011 | EP1294746B1 Peptide conjugates modified n- and/or c-terminally by short charged peptide chains |
| 05/04/2011 | EP0815233B1 Novel avian cytokines and genetic sequences encoding same |
| 05/04/2011 | CN1933805B Cosmetic or dermopharmaceutical medicine for reducing wrinkle because of age |
| 05/04/2011 | CN1918131B Novel inhibitors of glutaminyl cyclase |
| 05/04/2011 | CN1864822B Separating film for removing carbon monoxide, separating film assembly, method and device, an oxygen carrier with carbon monoxide removed and its pharmaceutical composition |
| 05/04/2011 | CN1863504B Long term drug delivery devices with polyurethane based polymers |
| 05/04/2011 | CN1826349B Wound care compositions |
| 05/04/2011 | CN102046661A Polypeptide-polymer conjugates and methods of use thereof |
| 05/04/2011 | CN102046652A Highly bridged peptides from Actinomadura namibiensis |
| 05/04/2011 | CN102046648A Hepatitis c virus inhibitors |
| 05/04/2011 | CN102046622A Novel macrocyclic inhibitors of hepatitis C virus replication |
| 05/04/2011 | CN102046194A Drug, dental material, and screening method |
| 05/04/2011 | CN102046193A Compositions and methods for using cells to treat heart tissue |
| 05/04/2011 | CN102046192A Compositions of GnRH related compounds and processes of preparation |
| 05/04/2011 | CN102046188A Compositions and methods using stem cells in cutaneous wound healing |
| 05/04/2011 | CN102046169A Methods for increasing absorption of peptides, peptidomimetics, and other gastrointestinal transport protein substrates |
| 05/04/2011 | CN102046168A PAI-1 expression and activity inhibitors for the treatment of ocular disorders |
| 05/04/2011 | CN102046166A Methods of treating dry eye |
| 05/04/2011 | CN102041263A Chicken alpha interferon/interleukin 2 chimeric gene |
| 05/04/2011 | CN102041238A Lactobacillus plantarum, method for fermenting and preparing bacteriocin of Lactobacillus plantarum, and application of Lactobacillus plantarum and bacteriocin |
| 05/04/2011 | CN102040654A Polypeptide TF1 for inhibiting activity of shiga toxin (stx) 2 and coding gene and application of stx2 |
| 05/04/2011 | CN102039000A Transdermal administration kit |
| 05/04/2011 | CN102038940A Hirudin combination medicament for treating cardiovascular and cerebrovascular diseases |
| 05/04/2011 | CN102038939A Preparation method of adenosine triphosphate coenzyme insulin freeze-dried powder injection |
| 05/04/2011 | CN102038938A Therapies for chronic inflammatory demyelinating polyneuropathy using interferon-beta |
| 05/04/2011 | CN102038937A External medicament for treating dermatosis and anti-aging and preparation method thereof |
| 05/04/2011 | CN102038936A Application of SIRT1 (silent mating type information regulation-1) in preparing upregulation globin gene expression and preparing medicine for curing anemia |
| 05/04/2011 | CN102038935A Application of Cucurmosin in preparation of medicaments for treating cervical cancer |
| 05/04/2011 | CN102038934A Application of cucurmosin in preparation of drug for treating breast cancer |
| 05/04/2011 | CN102038933A Combination of cyclosporine A and alkylation serum albumin and preparation method thereof |
| 05/04/2011 | CN102038932A Metal-binding compounds and uses therefor |
| 05/04/2011 | CN102038707A Method for preventing and treating sow metritis |
| 05/04/2011 | CN102038649A Urine-promoted follicle stimulating hormone freeze-drying powder injection and preparation method thereof |
| 05/04/2011 | CN101703480B Gelatin-chitosan/montmorillonite drug carried microspheres and preparation method thereof |
| 05/04/2011 | CN101649313B Application of recombinant pichia pastoris bacterial strain |
| 05/04/2011 | CN101548961B Novel oral capsule preparation for curing diabetes mellitus and obesity |
| 05/04/2011 | CN101519438B Cyclic peptide compound in Hsisha sponge and application thereof |
| 05/04/2011 | CN101391098B Apitoxin liposome preparation and preparation method thereof |
| 05/04/2011 | CN101367873B Modified glucagon sample peptide-1analogue and modifying matter, and uses thereof |
| 05/04/2011 | CN101366949B Method for improving feed efficiency and/or growth rate and/or fat reduction of livestock |
| 05/04/2011 | CN101319244B Method of preparing glutathione freeze-dried powder |
| 05/04/2011 | CN101314617B Novel snake venom polypeptide, preparation and application thereof |
| 05/04/2011 | CN101215544B Inflammation-inhibiting compounds |
| 05/04/2011 | CN101115839B Method for inhibiting fibrogenesis by an rhdecorin-fc fusion protein |
| 05/04/2011 | CN101066993B Recombinant staphylococcus aureus enterotoxin M and its preparation and application |
| 05/04/2011 | CN101005853B Therapeutic composition with a botulinum neurotoxin |
| 05/03/2011 | US7935805 Polynucleotides encoding antigenic HIV Type C polypeptides, polypeptides and uses thereof |
| 05/03/2011 | US7935786 Pharmacologically active peptide conjugates having a reduced tendency towards enzymatic hydrolysis |
| 05/03/2011 | US7935784 Immunoglobulin fusion which targets extracellullar domain of human estrogen receptor for use in diagnosis, prevention and treatment of cell proliferative disorders |
| 05/03/2011 | US7935714 Compositions for sleeping disorders |
| 05/03/2011 | US7935692 Polyamine compounds are used to mobilize and harvest CD34+ cells via apheresis with and without combinations with other mobilizing factors; bind to chemokine receptors; regeneration of heart tissue |
| 05/03/2011 | US7935682 Wound healing dressing for enhancing fibrocyte formation |
| 05/03/2011 | US7935671 Pantropic neurotrophic factors |